Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Depression and Anxiety|October 16, 2007
Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebosDarcy A Santor, David Debrota, Nina Engelhardt, et al.Clinicoeconomics and Outcomes Research : CEOR|February 18, 2020
Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims DatabasesKrista M Schroeder, Steve Gelwicks, April N Naegeli, et al.International Clinical Psychopharmacology|August 14, 2010
Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorderXianchen Liu, Steve Gelwicks, Douglas E Faries, et al.Journal of Psychiatric Research|March 9, 2004
An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companiesKenneth R Evans, Terrence Sills, David J DeBrota, et al.Current Medical Research and Opinion|November 5, 2014
Predictors of 30 day hospital readmission in patients with type 2 diabetes: a retrospective, case-control, database studyElizabeth Eby, Christine Hardwick, Maria Yu, et al.The American Journal of Gastroenterology|November 6, 2020
Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims AnalysisKatherine Cappell, Aliki Taylor, Barbara H Johnson, et al.Current Medical Research and Opinion|January 5, 2018
Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacineCliff Molife, Virginia S Haynes, Allen Nyhuis, et al.The Journal of Pain|June 6, 2006
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic painEric Q Wu, Howard G Birnbaum, Milena N Mareva, et al.Pageof 1